These findings establish a mechanistic link between TME‐driven NK cell dysfunction and GR‐associated transcriptional rewiring, offering insight into the compromised anti‐tumor efficacy of NK cells in therapeutic settings. This evidence concerns the gene NR3C1 and neoplasm.